Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2014

Open Access 01.12.2014 | Case report

Splenic hamartomas in two children

verfasst von: Li-Feng Zhang, Jin-Fa Tou, Xiang Wang, Wei-Zhong Gu, Xiao-Hui Ma, Qi Qin

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2014

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Hamartomas are extremely rare splenic benign tumours in children. We present two cases, both in boys (6 and 8 years old), with left upper quadrant abdominal pain that were otherwise asymptomatic. Both patients showed a splenic mass on preoperative ultrasonography and magnetic resonance imaging (MRI). One patient had a focal splenic mass that was identified preoperatively with contrasted computed tomography (CT) scans. Both patients underwent a total splenectomy. Although multi-modality imaging findings were described preoperatively, the final diagnosis in each case was splenic hamartoma based on histology and immunohistochemistry. The postoperative courses were uneventful.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1477-7819-12-180) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

LFZ and QQ drafted the manuscript. JFT, WX, WZG, and XHM also assisted with manuscript preparation. QQ revised the manuscript. All authors have read and approved the final manuscript.

Background

Splenic tumours are relatively rare and include malignancies such as lymphomas, angiosarcomas, plasmacytomas, primary malignant fibrous histiocytomas, and metastatic disease. Benign splenic tumours are extremely rare and most are hemangiomas, cysts, and inflammatory pseudotumours [1, 2]. Splenic hamartomas or splenomas, which were described in 1861 by Rokitansky, are extremely rare benign tumours with fewer than 150 cases having been reported in the literature [3]. The majority of these cases were found in adult patients, and only 20% of the cases were in children [4]. Although splenic hamartomas are mostly asymptomatic, particularly in adults, their association with myeloproliferative diseases and thrombocytopenia have been reported [4, 5]. However, these have not been well characterised in children. Here, we report the cases of two paediatric patients with a solid lesion of the spleen, who required splenectomies and were pathologically diagnosed with splenic hamartomas.

Case presentation

Case 1

An 8-year-old boy was incidentally diagnosed with a splenic mass by abdominal ultrasonography and admitted to our hospital for further investigation. He had no significant past medical history. The physical examination and the laboratory findings (such as blood routine test, serum chemistry test, and tumour biomarkers) on admission were unremarkable. Abdominal ultrasonography showed an isoechoic oval-shaped mass with smooth, well-defined borders in the mid-portion of the spleen that was 5.2 cm × 4.2 cm × 3.4 cm in size, within homogeneous echo (Figure 1A). Colour Doppler showed increased internal blood flow within the mass. Non-enhanced CT showed a slightly lower-density mass with poorly-defined margins in the spleen. A contrast-enhanced CT scan showed mild diffuse heterogeneous enhancement after the intravenous administration of contrast material (Figure 1B–C). Magnetic resonance imaging (MRI) showed a hypointense mass in the T1WI image that was slightly hyperintense in the T2WI image (Figure 1D–E). The lesion showed moderate enhancement on gadolinium-enhanced MRI (Figure 1F). The differential diagnosis included hemangiomas, angiosarcomas, primary splenic lymphoma, and inflammatory lesions, such as inflammatory pseudotumour. A malignancy could not be ruled out; therefore, the patient underwent a total splenectomy. Microscopically, the nodule consisted of disorganised vascular channels lined with slightly plump endothelial cells, the muscular small blood vessels and fibrous tissue had proliferated and white pulp was visible, but was significantly reduced. On immunohistochemical staining the nodule was CD34– and CD8+, and the final diagnosis was splenic hamartoma. The platelet count began to rise slowly on the 7th postoperative day and reached 1,000 × 109/L on postoperative day 14. Postoperative anticoagulant prophylaxis with oral aspirin was initiated and continued for 4 weeks after surgery. Finally, the patient was discharged from the hospital on the 15th postoperative day. No complications developed during postoperative follow-up, and the patient was asymptomatic 5 years after surgery.

Case 2

A 6-year-old boy was admitted to our department due to a 1-year history of left upper quadrant abdominal pain and worsening sickness for 1 week. Physical examination revealed a palpable spleen 3 cm below the costal margin. He had no significant past medical history, and the laboratory findings (such as blood routine test, serum chemistry test, and tumour biomarker) were also unremarkable. Abdominal ultrasonography showed a hypoechoic mass with well-defined borders in the lower pole of the spleen that measured 9.4 cm × 8.9 cm × 6.4 cm in size, within heterogeneous echo (Figure 2A). Colour Doppler showed increased internal blood flow within the mass. Magnetic resonance imaging (MRI) showed a slightly hyperintense signal in the T1WI and T2WI images and a non-homogeneous signal within the lesion (Figure 2B–D). The differential diagnosis included hemangiomas, angiosarcomas, and primary splenic lymphoma. Due to the risk of spontaneous rupture and the fact that malignancy could not be ruled out, the patient underwent a total splenectomy. Microscopically, the lesion contained a mixture of unorganised vascular channels and fibrotic cords within the splenic red pulp-like area (Figure 3A–B). The rest of the spleen showed unremarkable histology of red and white pulp. On immunohistochemical staining the tissue was CD8+, CD31+, and CD34–, and the final diagnosis was splenic hamartoma (Figure 3C–D). The platelet count increased to 1,108 × 109/L on the 7th day after surgery. Postoperative anticoagulant prophylaxis with oral aspirin was initiated and continued for 4 weeks after surgery. Finally, the patient was discharged from the hospital on the 13th postoperative day. No complications developed during postoperative follow-up, and the patient was asymptomatic 17 months after surgery.

Discussion

Splenic hamartomas are rare benign tumours with a reported incidence of 3 in 200,000 splenectomies in a single centre series [6]. The incidence of splenic hamartomas in autopsy series ranges between 0.024% and 0.13% [7].
Although most of the reports in the literature consist of adult patients [4, 8], smaller reviews indicate that 20% of hamartomas occur in children, with only 30 cases having been reported in the literature [4, 911] in addition to the two cases reported here. Overall, there were 19 males and 11 females. Nineteen of these patients had a hematologic abnormality such as anaemia, thrombocytopenia, or pancytopenia, and the specific diagnoses included bone marrow failure syndrome, sickle cell anaemia, hereditary spherocytosis, or congenital dyserythropoietic anaemia. Only 15% of the patients present with symptoms, most commonly abdominal pain, splenomegaly, cytopenia, and incidental spontaneous rupture [3, 12]. However, most children present with systemic symptoms such as fever and lethargy [4, 911].
Although the final diagnosis of splenic hamartomas is established by a pathological examination, a preoperative diagnosis using a combination of multi-modality imaging techniques may be possible [9, 1214]. On sonography, most hamartomas are hyperechoic relative to the adjacent normal splenic parenchyma [15]. Some splenic hamartomas are homogeneous and well-defined solid masses, with varying echogenicity relative to the normal splenic parenchyma, but others may be heterogeneous with cystic changes [12, 16]. Colour Doppler sonography may reveal blood-flow signals within the lesions [14]. Splenic hamartomas do not always exhibit hypervascularity because some are hypoechoic and are composed of red pulp, lacking fibrous trabeculae and white pulp [16]. However, the hypoechoic lesion in patient 2 contained a mixture of unorganised vascular channels and fibrotic cords of splenic red pulp-like areas on histological examination. On unenhanced CT images, most splenic hamartomas are homogeneous, or heterogeneous low-density or isodense masses with occasional calcification [12, 14]. Histopathological fibrous splenic hamartomas have a dominant fibrous tissue and MRI showed isointensity or hyperintensity on T1WI images and hypointensity on T2WI images [17]. Non-fibrous splenic hamartomas are more common in the clinic, and MRI revealed an isointense mass on T1WI images and mild hyperintense mass on T2WI images [13]. Dynamic enhanced CT and MRI are essential for suspected splenic hamartomas because of the differences from other splenic lesions. On delayed images, the density or signal of the lesion is near or slightly higher than that of the splenic parenchyma [12]. Hyperintense lesions on T2WI in both of our patients contained minimal fibrous tissue on histological examination. Therefore, sonography is a more sensitive modality than CT and MRI, which is useful for screening. CT and MRI can display components of the tumour, which are helpful for qualitative diagnosis.
Splenic hamartomas should be differentiated from the more common neoplastic disorders of the spleen such as hemangiomas and ominous lesions of the spleen including primary haemangiosarcomas, lymphomas, and metastases [12]. The main pathologic differential diagnosis is with benign vascular tumours or hemangiomas and immunohistochemical staining is required to confirm the diagnosis [4, 18]. Hamartomas represent an anomalous cluster of normal splenic red pulp elements. They contain a mixture of unorganised vascular channels lined by endothelial cells and are surrounded by fibrotic cords of predominant splenic red pulp with or without (lymphoid) white pulp [19]. Because of their origin from splenic sinusoids, endothelial cells of hamartomas are CD8+ and CD34– [20]. This staining pattern also differentiates them from splenic hemangiomas, which contain CD8– and CD34+ endothelial cells.

Conclusions

In conclusion, although splenic hamartomas are very rare tumours, they must be considered in the differential diagnosis of splenic lesions in children. However, a splenectomy may be necessary when malignancy cannot be ruled out preoperatively.
Written informed consent was obtained from the patients for publication of this report and any accompanying images.
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://​creativecommons.​org/​licenses/​by/​2.​0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( https://​creativecommons.​org/​publicdomain/​zero/​1.​0/​ ) applies to the data made available in this article, unless otherwise stated.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

LFZ and QQ drafted the manuscript. JFT, WX, WZG, and XHM also assisted with manuscript preparation. QQ revised the manuscript. All authors have read and approved the final manuscript.
Anhänge

Authors’ original submitted files for images

Literatur
2.
Zurück zum Zitat PisaniCeretti A, Bislenghi G, Virdis M, Maroni N, Gatti A, Opocher E: Laparoscopic splenectomy for splenic hamartoma: a case report. Case Rep Gastrointest Med. 2012, 2012: 435802- PisaniCeretti A, Bislenghi G, Virdis M, Maroni N, Gatti A, Opocher E: Laparoscopic splenectomy for splenic hamartoma: a case report. Case Rep Gastrointest Med. 2012, 2012: 435802-
3.
Zurück zum Zitat Basso SM, Sulfaro S, Marzano B, Fanti G, Chiara GB, Lumachi F: Incidentally discovered asymptomatic splenic hamartoma with rapidly expansive growth: a case report. In Vivo. 2012, 26 (6): 1049-1052.PubMed Basso SM, Sulfaro S, Marzano B, Fanti G, Chiara GB, Lumachi F: Incidentally discovered asymptomatic splenic hamartoma with rapidly expansive growth: a case report. In Vivo. 2012, 26 (6): 1049-1052.PubMed
4.
Zurück zum Zitat Abramowsky C, Alvarado C, Wyly JB, Ricketts R: “Hamartoma” of the spleen (splenoma) in children. Pediatr Dev Pathol. 2004, 7 (3): 231-236.CrossRefPubMed Abramowsky C, Alvarado C, Wyly JB, Ricketts R: “Hamartoma” of the spleen (splenoma) in children. Pediatr Dev Pathol. 2004, 7 (3): 231-236.CrossRefPubMed
5.
Zurück zum Zitat Tsitouridis I, Michaelides M, Tsitouridis K, Davidis I, Efstratiou I: Symptomatic splenoma (hamartoma) of the spleen. Hippokratia. 2010, 14 (1): 54-56.PubMedCentralPubMed Tsitouridis I, Michaelides M, Tsitouridis K, Davidis I, Efstratiou I: Symptomatic splenoma (hamartoma) of the spleen. Hippokratia. 2010, 14 (1): 54-56.PubMedCentralPubMed
6.
Zurück zum Zitat Silverman ML, LiVolsi VA: Splenic hamartoma. Am J Clin Pathol. 1978, 70 (2): 224-229.PubMed Silverman ML, LiVolsi VA: Splenic hamartoma. Am J Clin Pathol. 1978, 70 (2): 224-229.PubMed
7.
Zurück zum Zitat Lam KY, Yip KH, Peh WC: Splenic vascular lesions: unusual features and a review of the literature. Aust N Z J Surg. 1999, 69 (6): 422-425. 10.1046/j.1440-1622.1999.01550.x.CrossRefPubMed Lam KY, Yip KH, Peh WC: Splenic vascular lesions: unusual features and a review of the literature. Aust N Z J Surg. 1999, 69 (6): 422-425. 10.1046/j.1440-1622.1999.01550.x.CrossRefPubMed
8.
Zurück zum Zitat Falk S, Stutte HJ: Hamartomas of the spleen: a study of 20 biopsy cases. Histopathology. 1989, 14 (6): 603-612. 10.1111/j.1365-2559.1989.tb02201.x.CrossRefPubMed Falk S, Stutte HJ: Hamartomas of the spleen: a study of 20 biopsy cases. Histopathology. 1989, 14 (6): 603-612. 10.1111/j.1365-2559.1989.tb02201.x.CrossRefPubMed
9.
Zurück zum Zitat Avila L, Sivaprakasam P, Viero S, Somers GR, Shago M, Gerstle JT, Metser U, Gupta AA: Splenic hamartoma in a child in the era of PET-CT. Pediatr Blood Cancer. 2009, 53 (1): 114-116. 10.1002/pbc.21962.CrossRefPubMed Avila L, Sivaprakasam P, Viero S, Somers GR, Shago M, Gerstle JT, Metser U, Gupta AA: Splenic hamartoma in a child in the era of PET-CT. Pediatr Blood Cancer. 2009, 53 (1): 114-116. 10.1002/pbc.21962.CrossRefPubMed
10.
Zurück zum Zitat Benkirane A, Berrebi D, Olaya N, Ferkdadji L, Chomette PP, Benkerrou M, Peuchmaur M: [Hamartoma of the spleen (splenoma) in a child with sickle cell anemia]. Ann Pathol. 2007, 27 (1): 27-30. 10.1016/S0242-6498(07)88681-0.CrossRefPubMed Benkirane A, Berrebi D, Olaya N, Ferkdadji L, Chomette PP, Benkerrou M, Peuchmaur M: [Hamartoma of the spleen (splenoma) in a child with sickle cell anemia]. Ann Pathol. 2007, 27 (1): 27-30. 10.1016/S0242-6498(07)88681-0.CrossRefPubMed
11.
Zurück zum Zitat Shah P, Robbani I, Khan AB, Shah OJ: Symptomatic splenoma in a child. Ann Saudi Med. 2009, 29 (3): 236-238.PubMed Shah P, Robbani I, Khan AB, Shah OJ: Symptomatic splenoma in a child. Ann Saudi Med. 2009, 29 (3): 236-238.PubMed
12.
Zurück zum Zitat Wang JH, Ma XL, Ren FY, Zuo CJ, Tian JM, Wang ZF, Zheng JM: Multi-modality imaging findings of splenic hamartoma: a report of nine cases and review of the literature. Abdom Imaging. 2013, 38 (1): 154-162. 10.1007/s00261-012-9880-8.CrossRefPubMed Wang JH, Ma XL, Ren FY, Zuo CJ, Tian JM, Wang ZF, Zheng JM: Multi-modality imaging findings of splenic hamartoma: a report of nine cases and review of the literature. Abdom Imaging. 2013, 38 (1): 154-162. 10.1007/s00261-012-9880-8.CrossRefPubMed
13.
Zurück zum Zitat Elsayes KM, Narra VR, Mukundan G, Lewis JS, Menias CO, Heiken JP: MR imaging of the spleen: spectrum of abnormalities. Radiographics. 2005, 25 (4): 967-982. 10.1148/rg.254045154.CrossRefPubMed Elsayes KM, Narra VR, Mukundan G, Lewis JS, Menias CO, Heiken JP: MR imaging of the spleen: spectrum of abnormalities. Radiographics. 2005, 25 (4): 967-982. 10.1148/rg.254045154.CrossRefPubMed
14.
Zurück zum Zitat Tang S, Shimizu T, Kikuchi Y, Shinya S, Kishimoto R, Fujioka Y, Miyasaka K: Color Doppler sonographic findings in splenic hamartoma. J Clin Ultrasound. 2000, 28 (5): 249-253. 10.1002/(SICI)1097-0096(200006)28:5<249::AID-JCU7>3.0.CO;2-O.CrossRefPubMed Tang S, Shimizu T, Kikuchi Y, Shinya S, Kishimoto R, Fujioka Y, Miyasaka K: Color Doppler sonographic findings in splenic hamartoma. J Clin Ultrasound. 2000, 28 (5): 249-253. 10.1002/(SICI)1097-0096(200006)28:5<249::AID-JCU7>3.0.CO;2-O.CrossRefPubMed
15.
Zurück zum Zitat Ali TZ, Beyer G, Taylor M, Volpe C, Papadimitriou JC: Splenic hamartoma: immunohistochemical and ultrastructural profile of two cases. Int J Surg Pathol. 2005, 13 (1): 103-111. 10.1177/106689690501300116.CrossRefPubMed Ali TZ, Beyer G, Taylor M, Volpe C, Papadimitriou JC: Splenic hamartoma: immunohistochemical and ultrastructural profile of two cases. Int J Surg Pathol. 2005, 13 (1): 103-111. 10.1177/106689690501300116.CrossRefPubMed
16.
Zurück zum Zitat Nakanishi S, Shiraki K, Yamamoto K, Nakano T, Koyama M, Yano T, Sanda T, Tamaki H, Hirano T, Fukudome K, Ishihara A: Basket pattern blood flow signals discovered in a case of splenic hamartoma by power Doppler ultrasonography. World J Gastroenterol. 2005, 11 (33): 5235-5238.PubMedCentralPubMed Nakanishi S, Shiraki K, Yamamoto K, Nakano T, Koyama M, Yano T, Sanda T, Tamaki H, Hirano T, Fukudome K, Ishihara A: Basket pattern blood flow signals discovered in a case of splenic hamartoma by power Doppler ultrasonography. World J Gastroenterol. 2005, 11 (33): 5235-5238.PubMedCentralPubMed
17.
Zurück zum Zitat Chevallier P, Guzman E, Fabiani P, Dib M, Oddo F, Padovani B: [Fibrous splenic hamartoma: imaging features]. J Radiol. 1999, 80 (12): 1668-1671.PubMed Chevallier P, Guzman E, Fabiani P, Dib M, Oddo F, Padovani B: [Fibrous splenic hamartoma: imaging features]. J Radiol. 1999, 80 (12): 1668-1671.PubMed
18.
Zurück zum Zitat Sankar S, Thanka J, Jagdishchandrabose S, Rajendran S: Splenic hamartoma: a rare vascular space occupying lesion of the spleen. Indian J Pathol Microbiol. 2011, 54 (1): 223-225. 10.4103/0377-4929.77416.CrossRefPubMed Sankar S, Thanka J, Jagdishchandrabose S, Rajendran S: Splenic hamartoma: a rare vascular space occupying lesion of the spleen. Indian J Pathol Microbiol. 2011, 54 (1): 223-225. 10.4103/0377-4929.77416.CrossRefPubMed
19.
Zurück zum Zitat Abbott RM, Levy AD, Aguilera NS, Gorospe L, Thompson WM: From the archives of the AFIP: primary vascular neoplasms of the spleen: radiologic-pathologic correlation. Radiographics. 2004, 24 (4): 1137-1163. 10.1148/rg.244045006.CrossRefPubMed Abbott RM, Levy AD, Aguilera NS, Gorospe L, Thompson WM: From the archives of the AFIP: primary vascular neoplasms of the spleen: radiologic-pathologic correlation. Radiographics. 2004, 24 (4): 1137-1163. 10.1148/rg.244045006.CrossRefPubMed
20.
Zurück zum Zitat Zukerberg LR, Kaynor BL, Silverman ML, Harris NL: Splenic hamartoma and capillary hemangioma are distinct entities: immunohistochemical analysis of CD8 expression by endothelial cells. Hum Pathol. 1991, 22 (12): 1258-1261. 10.1016/0046-8177(91)90108-2.CrossRefPubMed Zukerberg LR, Kaynor BL, Silverman ML, Harris NL: Splenic hamartoma and capillary hemangioma are distinct entities: immunohistochemical analysis of CD8 expression by endothelial cells. Hum Pathol. 1991, 22 (12): 1258-1261. 10.1016/0046-8177(91)90108-2.CrossRefPubMed
Metadaten
Titel
Splenic hamartomas in two children
verfasst von
Li-Feng Zhang
Jin-Fa Tou
Xiang Wang
Wei-Zhong Gu
Xiao-Hui Ma
Qi Qin
Publikationsdatum
01.12.2014
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2014
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-12-180

Weitere Artikel der Ausgabe 1/2014

World Journal of Surgical Oncology 1/2014 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.